MarketInOut Stock Screener Log In | Sign Up

Arcturus Therapeutics Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Arcturus Therapeutics Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization313.51 mln
Float26.05 mln
Earnings Date11/05/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-4.44
Highly reliable

1-Year Forecast

23.80
Transformational upside

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-498%
Severely loss-making

Business Description

Arcturus Therapeutics is a San Diego-based medicine company founded in 2013 that uses mRNA technology to create treatments for rare liver and respiratory diseases, as well as vaccines for infectious illnesses like COVID-19 and influenza. The company has developed its own delivery system to get these medicines into the body effectively, and several of its treatments are currently being tested in clinical trials. Its most advanced programs target cystic fibrosis and a rare liver disorder that prevents the body from processing certain proteins.

Key Fundamentals

EPS-3.33
ROE-45.16
RPS1.05
ROIC-188
ROA-35.00
EBITDA, mln-90.54
EV / EBITDA-1.66
EV / EBIT-1.61
Revenue, mln18.72
EV / Revenue8.05

Quote Details

Last 11.03
Change -1.12 (-9.22%)
Open 11.81
Volume 1,546,093
Turnover 17,053,406
Average Volume 696,960

Financial Ratios

Pre-Tax Profit Margin-498
Leverage Ratio1.31
Current Ratio5.88
Price / Book1.86
Price / Tangible Book1.86
Debt / Equity0.13
Price / Sales16.44

Financial Strength

Altman Z-Score-0.72
Piotroski F-Score 1 / 9
Beneish M-Score-4.44
1-Year Target Price23.80
Short Ratio6.99
Short % of Float23.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.09% 95 / 100   
1 Month -16.5% 22 / 100   
2 Months 91.49% 99 / 100   
6 Months 27.81% 92 / 100   
1 Year 16.84% 77 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog